Antimicrobial Resistance Mechanisms in Staphylococcus aureus

Staphylococcus aureus employs a multifaceted arsenal to evade the action of antibiotics. Central to β-lactam resistance is the mecA determinant, which encodes penicillin-binding protein 2a (PBP2a) with reduced affinity for β-lactam rings, allowing continued cell-wall synthesis in the presence of penicillins, cephalosporins and carbapenems. A complementary system involves inducible expression of β-lactamases through the BlaR1–BlaI two-component sensor–repressor module. Modifications of target sites, such as mutations in ribosomal RNA or in the 23S subunit, confer resistance to macrolides, lincosamides and streptogramin B antibiotics. Active efflux pumps, including NorA and MepA, expel fluoroquinolones and other compounds, while enzymatic inactivation mechanisms underlie aminoglycoside and trimethoprim resistance. Alterations in cell-wall thickness and charge reduce the binding and penetration of glycopeptides and daptomycin. Horizontal acquisition of mobile genetic elements—plasmids, transposons and staphylococcal cassette chromosome mec (SCCmec)—disseminates resistance determinants across clinical, community and livestock reservoirs. Biofilm formation further impairs antibiotic penetration and fosters persistence in chronic infections. Together, these mechanisms underscore the adaptability of S. aureus and the imperative for novel therapeutic and diagnostic strategies.

Research from Nature Portfolio

Recent studies have provided atomic-level insight into the initial sensing and activation steps of β-lactam resistance. High-resolution cryo-electron microscopy structures of the BlaR1 receptor reveal a domain-swapped dimerisation and the conformational transitions triggered by β-lactam binding. These structures clarify how acylation of the sensor domain induces transmembrane signalling that activates the metalloprotease domain to cleave the BlaI repressor, unleashing expression of both β-lactamase and mecA. Detailed mapping of the autocleavage site and the allosteric pathways within BlaR1 offers a blueprint for the design of inhibitors that could block the signal transduction cascade at its inception. This work establishes a structural paradigm for two-component signalling in antibiotic resistance and identifies novel molecular targets to disarm broad-spectrum β-lactam resistance.

Antimicrobial Resistance Mechanisms in Staphylococcus aureus publication trend

The graph below shows the total number of articles in antimicrobial resistance mechanisms in staphylococcus aureus across all publications each year (not limited to Nature Index journals).

Technical terms

β-lactamase: Enzyme that hydrolyses the β-lactam ring, rendering penicillins and cephalosporins inactive.

mecA: Gene encoding PBP2a, a low-affinity penicillin-binding protein responsible for methicillin resistance.

PBP2a: Altered transpeptidase that cross-links peptidoglycan in the presence of β-lactams.

SCCmec: Mobile genetic element carrying mecA and associated regulatory genes, facilitating horizontal transfer of methicillin resistance.

Antimicrobial peptide (AMP): Short cationic peptide that can disrupt bacterial processes or potentiate antibiotic action without membrane lysis.

References

1. Structural basis of broad-spectrum β-lactam resistance in Staphylococcus aureus. Nature (2023).
2. Non‐Membrane Active Peptide Resensitizes MRSA to β‐Lactam Antibiotics and Inhibits S. aureus Virulence. Advanced Science (2025).
3. Molecular Mechanisms of Drug Resistance in Staphylococcus aureus. International Journal of Molecular Sciences (2022).